Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.40 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.40 |
| ▸ | ITGAL | P20701 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 6/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7462192 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL28183039 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL6677657 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL8336950 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL8339391 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL2162449 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL8781563 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL1473003 | 1.00 | MEN1 (0.43) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL151539 | 0.98 | MEN1 (0.44) | MEN1KMT2AECE1ALDH1A1RAB9A | |
| SCHEMBL9015921 | 0.98 | MEN1 (0.44) | MEN1KMT2AECE1ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109880803-B | Chimeric proteins, immune effector cells expressing chimeric proteins and uses thereof | 恺兴生命科技(上海)有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-113462661-B | SIZ1 protein separated from corn, encoding gene thereof and application thereof in variety improvement | 华南农业大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-113929706-B | Compound with anticancer effect | 中国科学院分子植物科学卓越创新中心 | 2024-04-16 | — | — | CN | disclosed |
| CN-117836002-A | Hepatitis c virus immunogenic compositions and methods of use thereof | 奥罗拉疫苗有限责任公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117677287-A | Plant protection agent based on chitinase | 环球化学股份有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117651774-A | Method for producing minus-strand RNA viral vector and minus-strand RNA viral vector produced thereby | 礼富利科技股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117580861-A | Treatment of PD-L1 negative or low expression cancers with anti-ICOS antibodies | 凯玛布有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-115057927-B | Peanut allergen Ara h1 specific nano-antibody and application thereof | 南开大学 | 2024-02-20 | — | — | CN | disclosed |
| CN-117561078-A | Biomarkers for assessing risk of developing acute covd-19 and post-acute covd-19 | 奥默罗斯公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-112608876-B | Living cell labeling method of biotinylated Curli protein and application thereof | 江苏大学 | 2024-02-09 | — | — | CN | disclosed |
| WO-1996004314-A1 | MHC COMPLEXES AND USES THEREOF | DADE INTERNATIONAL, INC. (US) | 1996-02-15 | — | — | WO | disclosed |
| EP-0694044-A1 | METHOD AND PRODUCT FOR REGULATING CELL RESPONSIVENESS TO EXTERNAL SIGNALS | NATIONAL JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE (US) | 1996-01-31 | — | — | EP | disclosed |
| WO-1995028421-A1 | METHOD AND PRODUCT FOR REGULATING CELL RESPONSIVENESS TO EXTERNAL SIGNALS | NATIONAL JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE (US) | 1995-10-26 | — | — | WO | disclosed |
| US-5457046-A | Polypeptides | NOVO NORDISK A/S (DK) | 1995-10-10 | — | — | US | disclosed |
| WO-1995010616-A2 | USE OF α-1,4-GLUCAN LYASE FOR PREPARATION OF 1,5-D-ANHYDROFRUCTOSE | DANISCO A/S (DK) | 1995-04-20 | — | — | WO | disclosed |
| WO-1995010618-A2 | ALPHA-1,4-GLUCAN LYASE FROM A FUNGUS INFECTED ALGAE, ITS PURIFICATION, GENE CLONING AND EXPRESSION IN MICROORGANISMS | DANISCO A/S (DK) | 1995-04-20 | — | — | WO | disclosed |
| WO-1995007990-A1 | A NOVEL G PROTEIN-COUPLED RECEPTOR KINASE GRK6 | ICOS CORPORATION (US) | 1995-03-23 | — | — | WO | disclosed |
| EP-0637318-A1 | PEPTIDE DERIVATIVES CORRESPONDING TO THE CARBOXY TERMINAL SEQUENCE OF HIRUDIN | Novartis AG (CH) | 1995-02-08 | — | — | EP | disclosed |
| WO-1994024159-A1 | METHOD AND PRODUCT FOR REGULATING CELL RESPONSIVENESS TO EXTERNAL SIGNALS | NATIONAL JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE (US) | 1994-10-27 | — | — | WO | disclosed |
| WO-1993022344-A1 | PEPTIDE DERIVATIVES CORRESPONDING TO THE CARBOXY TERMINAL SEQUENCE OF HIRUDIN | CIBA-GEIGY AG (CH) | 1993-11-11 | — | — | WO | disclosed |